|
Allowance of USA Patent
|
28 June 2023 at 5:50pm
|
|
Initial Director Interest Notice - A Ding
|
12 May 2023 at 9:55am
|
|
Initial Director Interest Notice - C Ramsey
|
12 May 2023 at 9:50am
|
|
BGT - Board Changes
|
12 May 2023 at 9:50am
|
|
Withdrawal of Section 203D and 249D Notices
|
11 May 2023 at 5:20pm
|
|
GRDC Confirms Support for Flavocide in Grain Storage
|
11 May 2023 at 10:55am
|
|
Bio-Gene Update Company Presentation
|
3 May 2023 at 11:15am
|
|
Appendix 4C - 31 March 2023
|
27 April 2023 at 9:25am
|
|
Synergy Studies Offer Significant Commercial Opportunities
|
26 April 2023 at 9:20am
|
|
Receipt of Section 203D and 249D Notices
|
26 April 2023 at 8:35am
|
|
Final Director's Interest Notice - J Joughin
|
24 April 2023 at 9:20am
|
|
Final Director's Interest Notice - P Beetham
|
24 April 2023 at 9:20am
|
|
Board and Management Changes
|
24 April 2023 at 9:20am
|
|
Bio-Gene Business Update and March Quarterly Briefing
|
20 April 2023 at 9:20am
|
|
Bio-Gene Extends Commercial Development Agreement
|
13 April 2023 at 9:25am
|
|
Impending Retirement of Director - James Joughin
|
21 March 2023 at 9:10am
|
|
Appointment of New CFO & Company Secretary
|
21 March 2023 at 9:05am
|
|
Allowance of United States Patent
|
17 March 2023 at 9:45am
|
|
Bio-Gene Company Update Presentation
|
23 February 2023 at 10:50am
|
|
Appendix 4D - Half Year Accounts - 31 December 2022
|
23 February 2023 at 10:20am
|
|
Appendix 4C - 31 December 2022
|
31 January 2023 at 9:20am
|
|
Bio-Gene Receives R&D Tax Incentive
|
20 January 2023 at 8:50am
|
|
Bio-Gene and STK Agree Binding Terms on Global Collaboration
|
19 January 2023 at 12:35pm
|
|
Trading Halt
|
18 January 2023 at 9:20am
|
|
Bio-Gene Manufacturing Update Webinar
|
12 December 2022 at 2:50pm
|
|
Bio-Gene Submits Application for Plant Breeders Rights
|
1 December 2022 at 9:45am
|
|
Bio-Gene to Present at Biocides Europe 2022
|
30 November 2022 at 9:20am
|
|
Amended Constitution
|
24 November 2022 at 5:45pm
|
|
Results of Meeting
|
18 November 2022 at 12:55pm
|
|
Bio-Gene 2022 AGM - CEO's Presentation
|
18 November 2022 at 12:35pm
|
|
Bio-Gene 2022 AGM Presentation
|
18 November 2022 at 12:25pm
|
|
Bio-Gene 2022 AGM - Chairman's Address
|
18 November 2022 at 12:25pm
|
|
Appendix 4C - 30 September 2022
|
27 October 2022 at 9:25am
|
|
Significant Developments in Molecule Manufacturing - Update
|
26 October 2022 at 10:00am
|
|
2022 Notice of Annual General Meeting/Proxy Form
|
14 October 2022 at 10:00am
|
|
Notice Required Under ASX Listing Rule 3.13.1
|
30 September 2022 at 8:45am
|
|
Appendix 4G and 2022 Corporate Governance Statement
|
16 August 2022 at 10:20am
|
|
Appendix 4E and 2022 Annual Report
|
16 August 2022 at 10:20am
|
|
Change of Director's Interest Notice - P May
|
5 August 2022 at 10:15am
|
|
Change of Director's Interest Notice - R Jagger
|
5 August 2022 at 10:15am
|
|
Notification of buy-back - BGT
|
5 August 2022 at 10:15am
|
|
Appendix 4C - 30 June 2022
|
28 July 2022 at 10:05am
|
|
Notification of buy-back - BGT
|
14 July 2022 at 5:05pm
|
|
Change of Director's Interest Notice - R Jagger
|
16 June 2022 at 4:50pm
|
|
Change of Director's Interest Notice - R Klupacs
|
16 June 2022 at 4:45pm
|
|
Update on Development Program with BASF
|
11 May 2022 at 10:05am
|
|
Bio-Gene to Present at Bioshares 16th Biotech Summit
|
11 May 2022 at 8:50am
|
|
Investor Presentation and Overview of Appendix 4C
|
27 April 2022 at 9:30am
|
|
Appendix 4C - 31 March 2022
|
27 April 2022 at 8:45am
|
|
Bio-Gene Executes Commercial Development Agreement
|
4 April 2022 at 8:59am
|
